| Year |
Citation |
Score |
| 2021 |
Lim HI, Hajjar KA. Annexin A2 in Fibrinolysis, Inflammation and Fibrosis. International Journal of Molecular Sciences. 22. PMID 34202091 DOI: 10.3390/ijms22136836 |
0.331 |
|
| 2021 |
Fassel H, Chen H, Ruisi M, Kumar N, DeSancho MT, Hajjar KA. Reduced Expression of Annexin A2 is Associated with Impaired Cell Surface Fibrinolysis and Venous Thromboembolism. Blood. PMID 33512476 DOI: 10.1182/blood.2020008123 |
0.36 |
|
| 2020 |
Dallacasagrande V, Hajjar KA. Annexin A2 in Inflammation and Host Defense. Cells. 9. PMID 32575495 DOI: 10.3390/Cells9061499 |
0.367 |
|
| 2019 |
Garrido-Gomez T, Quiñonero A, Dominguez F, Rubert L, Perales A, Hajjar KA, Simon C. Preeclampsia: a defect in decidualization is associated with deficiency of Annexin A2. American Journal of Obstetrics and Gynecology. PMID 31738896 DOI: 10.1016/J.Ajog.2019.11.1250 |
0.331 |
|
| 2019 |
Fassel H, Chen H, Ruisi M, De Sancho MT, Hajjar KA. Markedly Reduced Expression of Annexin A2 Is Associated with Hypofibrinolysis and Provoked and Unprovoked Venous Thromboembolism Blood. 134: 443-443. DOI: 10.1182/Blood-2019-127426 |
0.445 |
|
| 2018 |
Li W, Chen Z, Yuan J, Yu Z, Cheng C, Zhao Q, Huang L, Hajjar KA, Chen Z, Lo EH, Dai H, Wang X. Annexin A2 is a Robo4 ligand that modulates ARF6 activation-associated cerebral trans-endothelial permeability. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X18777916. PMID 29786451 DOI: 10.1177/0271678X18777916 |
0.404 |
|
| 2017 |
Luo M, Flood EC, Almeida D, Yan L, Berlin DA, Heerdt PM, Hajjar KA. Annexin A2 supports pulmonary microvascular integrity by linking vascular endothelial cadherin and protein tyrosine phosphatases. The Journal of Experimental Medicine. PMID 28694388 DOI: 10.1084/Jem.20160652 |
0.405 |
|
| 2017 |
Staquicini DI, Rangel R, Guzman-Rojas L, Staquicini FI, Dobroff AS, Tarleton CA, Ozbun MA, Kolonin MG, Gelovani JG, Marchiò S, Sidman RL, Hajjar KA, Arap W, Pasqualini R. Intracellular targeting of annexin A2 inhibits tumor cell adhesion, migration, and in vivo grafting. Scientific Reports. 7: 4243. PMID 28652618 DOI: 10.1038/S41598-017-03470-W |
0.419 |
|
| 2016 |
Salameh A, Daquinag AC, Staquicini DI, An Z, Hajjar KA, Pasqualini R, Arap W, Kolonin MG. Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue. Jci Insight. 1. PMID 27468426 DOI: 10.1172/Jci.Insight.86351 |
0.328 |
|
| 2016 |
Stukes S, Coelho C, Rivera J, Jedlicka AE, Hajjar KA, Casadevall A. The Membrane Phospholipid Binding Protein Annexin A2 Promotes Phagocytosis and Nonlytic Exocytosis of Cryptococcus neoformans and Impacts Survival in Fungal Infection. Journal of Immunology (Baltimore, Md. : 1950). PMID 27371724 DOI: 10.4049/Jimmunol.1501855 |
0.366 |
|
| 2016 |
Liu W, Hajjar KA. The annexin A2 system and angiogenesis. Biological Chemistry. PMID 27366903 DOI: 10.1515/Hsz-2016-0166 |
0.449 |
|
| 2015 |
Hajjar KA. The Biology of Annexin A2: From Vascular Fibrinolysis to Innate Immunity. Transactions of the American Clinical and Climatological Association. 126: 144-55. PMID 26330668 |
0.314 |
|
| 2015 |
Foley K, Rucki AA, Xiao Q, Zhou D, Leubner A, Mo G, Kleponis J, Wu AA, Sharma R, Jiang Q, Anders RA, Iacobuzio-Donahue CA, Hajjar KA, Maitra A, Jaffee EM, et al. Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer. Science Signaling. 8: ra77. PMID 26243191 DOI: 10.1126/Scisignal.Aaa5823 |
0.358 |
|
| 2015 |
Morozova K, Sridhar S, Zolla V, Clement CC, Scharf B, Verzani Z, Diaz A, Larocca JN, Hajjar KA, Cuervo AM, Santambrogio L. Corrigendum: Annexin A2 promotes phagophore assembly by enhancing Atg16⁺ vesicle biogenesis and homotypic fusion. Nature Communications. 6: 6816. PMID 25817270 DOI: 10.1038/Ncomms7816 |
0.333 |
|
| 2015 |
Morozova K, Sidhar S, Zolla V, Clement CC, Scharf B, Verzani Z, Diaz A, Larocca JN, Hajjar KA, Cuervo AM, Santambrogio L. Annexin A2 promotes phagophore assembly by enhancing Atg16L⁺ vesicle biogenesis and homotypic fusion. Nature Communications. 6: 5856. PMID 25597631 DOI: 10.1038/Ncomms6856 |
0.357 |
|
| 2015 |
Chapin JC, Hajjar KA. Fibrinolysis and the control of blood coagulation. Blood Reviews. 29: 17-24. PMID 25294122 DOI: 10.1016/J.Blre.2014.09.003 |
0.341 |
|
| 2015 |
Luo M, Chen H, West F, Almeida D, Worgall S, Hajjar K. Annexin A2 Modulates Bleomycin-Induced Interstitial Pulmonary Edema Chest. 148: 390A. DOI: 10.1378/Chest.2279544 |
0.336 |
|
| 2014 |
Bambino K, Lacko LA, Hajjar KA, Stuhlmann H. Epidermal growth factor-like domain 7 is a marker of the endothelial lineage and active angiogenesis. Genesis (New York, N.Y. : 2000). 52: 657-70. PMID 24740971 DOI: 10.1002/Dvg.22781 |
0.359 |
|
| 2014 |
Dassah M, Almeida D, Hahn R, Bonaldo P, Worgall S, Hajjar KA. Annexin A2 mediates secretion of collagen VI, pulmonary elasticity and apoptosis of bronchial epithelial cells. Journal of Cell Science. 127: 828-44. PMID 24357721 DOI: 10.1242/Jcs.137802 |
0.39 |
|
| 2013 |
Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H, Almeida D, Koller A, Hajjar KA, Stainier DY, Chen EI, Lyden D, Bissell MJ. The perivascular niche regulates breast tumour dormancy. Nature Cell Biology. 15: 807-17. PMID 23728425 DOI: 10.1038/Ncb2767 |
0.337 |
|
| 2013 |
Ruan J, Luo M, Wang C, Fan L, Yang SN, Cardenas M, Geng H, Leonard JP, Melnick A, Cerchietti L, Hajjar KA. Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes. Blood. 121: 5192-202. PMID 23632889 DOI: 10.1182/Blood-2013-03-490763 |
0.388 |
|
| 2013 |
Dai H, Yu Z, Fan X, Liu N, Yan M, Chen Z, Lo EH, Hajjar KA, Wang X. Dysfunction of annexin A2 contributes to hyperglycaemia-induced loss of human endothelial cell surface fibrinolytic activity. Thrombosis and Haemostasis. 109: 1070-8. PMID 23572070 DOI: 10.1160/Th12-12-0944 |
0.485 |
|
| 2013 |
Luo M, Hajjar KA. Annexin A2 system in human biology: cell surface and beyond. Seminars in Thrombosis and Hemostasis. 39: 338-46. PMID 23483454 DOI: 10.1055/S-0033-1334143 |
0.431 |
|
| 2013 |
Lanfranco J, Chen H, Harris K, Almeida D, Berlin D, Hajjar K. Decreased Expression of Surface Annexin A2 in Human Sepsis Syndrome Chest. 144: 408A. DOI: 10.1378/Chest.1704251 |
0.346 |
|
| 2012 |
Hedhli N, Falcone DJ, Huang B, Cesarman-Maus G, Kraemer R, Zhai H, Tsirka SE, Santambrogio L, Hajjar KA. The annexin A2/S100A10 system in health and disease: Emerging paradigms Journal of Biomedicine and Biotechnology. 2012. PMID 23193360 DOI: 10.1155/2012/406273 |
0.624 |
|
| 2012 |
Seidah NG, Poirier S, Denis M, Parker R, Miao B, Mapelli C, Prat A, Wassef H, Davignon J, Hajjar KA, Mayer G. Annexin A2 is a natural extrahepatic inhibitor of the PCSK9-induced LDL receptor degradation. Plos One. 7: e41865. PMID 22848640 DOI: 10.1371/Journal.Pone.0041865 |
0.369 |
|
| 2012 |
Scharf B, Clement CC, Wu XX, Morozova K, Zanolini D, Follenzi A, Larocca JN, Levon K, Sutterwala FS, Rand J, Cobelli N, Purdue E, Hajjar KA, Santambrogio L. Annexin A2 binds to endosomes following organelle destabilization by particulate wear debris. Nature Communications. 3: 755. PMID 22453828 DOI: 10.1038/Ncomms1754 |
0.396 |
|
| 2011 |
Zhai H, Acharya S, Gravanis I, Mehmood S, Seidman RJ, Shroyer KR, Hajjar KA, Tsirka SE. Annexin A2 promotes glioma cell invasion and tumor progression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 14346-60. PMID 21976520 DOI: 10.1523/Jneurosci.3299-11.2011 |
0.384 |
|
| 2011 |
Huang B, Deora AB, He KL, Chen K, Sui G, Jacovina AT, Almeida D, Hong P, Burgman P, Hajjar KA. Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice. Blood. 118: 2918-29. PMID 21788340 DOI: 10.1182/Blood-2011-03-341214 |
0.77 |
|
| 2011 |
Flood EC, Hajjar KA. The annexin A2 system and vascular homeostasis. Vascular Pharmacology. 54: 59-67. PMID 21440088 DOI: 10.1016/J.Vph.2011.03.003 |
0.443 |
|
| 2011 |
Cesarman-Maus G, Cantú-Brito C, Barinagarrementeria F, Villa R, Reyes E, Sanchez-Guerrero J, Hajjar KA, Latorre EG. Autoantibodies against the fibrinolytic receptor, annexin A2, in cerebral venous thrombosis. Stroke; a Journal of Cerebral Circulation. 42: 501-3. PMID 21193750 DOI: 10.1161/Strokeaha.110.592121 |
0.373 |
|
| 2011 |
He KL, Sui G, Xiong H, Broekman MJ, Huang B, Marcus AJ, Hajjar KA. Feedback regulation of endothelial cell surface plasmin generation by PKC-dependent phosphorylation of annexin A2. The Journal of Biological Chemistry. 286: 15428-39. PMID 21115493 DOI: 10.1074/Jbc.M110.185058 |
0.647 |
|
| 2011 |
Sarkar S, Swiercz R, Kantara C, Hajjar KA, Singh P. Annexin A2 mediates up-regulation of NF-κB, β-catenin, and stem cell in response to progastrin in mice and HEK-293 cells. Gastroenterology. 140: 583-595.e4. PMID 20826156 DOI: 10.1053/J.Gastro.2010.08.054 |
0.338 |
|
| 2011 |
Ruan J, Cerchietti L, Wang C, Fan L, Yang SN, Geng H, Leonard JP, Melnick A, Hajjar KA. Therapeutic Targeting of Lymphoma-Associated Vascular Pericytes, Blood. 118: 3725-3725. DOI: 10.1182/Blood.V118.21.3725.3725 |
0.383 |
|
| 2010 |
Fan X, Yu Z, Liu J, Liu N, Hajjar KA, Furie KL, Lo EH, Wang X. Annexin A2: a tissue plasminogen activator amplifier for thrombolytic stroke therapy. Stroke; a Journal of Cerebral Circulation. 41: S54-8. PMID 20876506 DOI: 10.1161/Strokeaha.110.596106 |
0.323 |
|
| 2010 |
Zhu H, Fan X, Yu Z, Liu J, Murata Y, Lu J, Zhao S, Hajjar KA, Lo EH, Wang X. Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 30: 1137-46. PMID 20068577 DOI: 10.1038/Jcbfm.2009.279 |
0.331 |
|
| 2009 |
Dassah M, Deora AB, He K, Hajjar KA. The endothelial cell annexin A2 system and vascular fibrinolysis. General Physiology and Biophysics. 28: F20-8. PMID 20093722 |
0.33 |
|
| 2009 |
Jacovina AT, Deora AB, Ling Q, Broekman MJ, Almeida D, Greenberg CB, Marcus AJ, Smith JD, Hajjar KA. Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. The Journal of Clinical Investigation. 119: 3384-94. PMID 19841537 DOI: 10.1172/Jci39591 |
0.779 |
|
| 2009 |
Romay-Penabad Z, Montiel-Manzano MG, Shilagard T, Papalardo E, Vargas G, Deora AB, Wang M, Jacovina AT, Garcia-Latorre E, Reyes-Maldonado E, Hajjar KA, Pierangeli SS. Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. Blood. 114: 3074-83. PMID 19628708 DOI: 10.1182/Blood-2008-11-188698 |
0.767 |
|
| 2009 |
Law AL, Ling Q, Hajjar KA, Futter CE, Greenwood J, Adamson P, Wavre-Shapton ST, Moss SE, Hayes MJ. Annexin A2 regulates phagocytosis of photoreceptor outer segments in the mouse retina. Molecular Biology of the Cell. 20: 3896-904. PMID 19587120 DOI: 10.1091/Mbc.E08-12-1204 |
0.399 |
|
| 2009 |
Huang B, Deora AB, Sui G, Hajjar KA. Hypoxia-Induced Annexin A2 Expression Regulates Oxygen-Induced Retinopathy. Blood. 114: 471-471. DOI: 10.1182/Blood.V114.22.471.471 |
0.637 |
|
| 2008 |
Ruan J, Hajjar K, Rafii S, Leonard JP. Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 20: 413-24. PMID 19088170 DOI: 10.1093/Annonc/Mdn666 |
0.365 |
|
| 2008 |
He KL, Deora AB, Xiong H, Ling Q, Weksler BB, Niesvizky R, Hajjar KA. Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11. The Journal of Biological Chemistry. 283: 19192-200. PMID 18434302 DOI: 10.1074/Jbc.M800100200 |
0.457 |
|
| 2007 |
Hajjar KA, Ruan J, Sui G, Deora AB, Church S, Cohen-Gould L, Rafii S, Lyden DC, Ling Q. Annexin 2 Mediates Plasminogen-Related Recruitment of Neovascular Mural Cells in Lymphoma Angiogenesis. Blood. 110: 3708-3708. DOI: 10.1182/Blood.V110.11.3708.3708 |
0.426 |
|
| 2006 |
Cesarman-Maus G, Ríos-Luna NP, Deora AB, Huang B, Villa R, Cravioto Mdel C, Alarcón-Segovia D, Sánchez-Guerrero J, Hajjar KA. Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood. 107: 4375-82. PMID 16493010 DOI: 10.1182/Blood-2005-07-2636 |
0.622 |
|
| 2006 |
Ballard VL, Sharma A, Duignan I, Holm JM, Chin A, Choi R, Hajjar KA, Wong SC, Edelberg JM. Vascular tenascin-C regulates cardiac endothelial phenotype and neovascularization. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 717-9. PMID 16461331 DOI: 10.1096/Fj.05-5131Fje |
0.334 |
|
| 2005 |
Cesarman-Maus G, Hajjar KA. Molecular mechanisms of fibrinolysis. British Journal of Haematology. 129: 307-21. PMID 15842654 DOI: 10.1111/J.1365-2141.2005.05444.X |
0.31 |
|
| 2004 |
Deora AB, Kreitzer G, Jacovina AT, Hajjar KA. An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface Journal of Biological Chemistry. 279: 43411-43418. PMID 15302870 DOI: 10.1074/Jbc.M408078200 |
0.765 |
|
| 2004 |
Ling Q, Jacovina AT, Deora A, Febbraio M, Simantov R, Silverstein RL, Hempstead B, Mark WH, Hajjar KA. Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. The Journal of Clinical Investigation. 113: 38-48. PMID 14702107 DOI: 10.1172/Jci19684 |
0.799 |
|
| 2004 |
Krishnan S, Deora AB, Annes JP, Osoria J, Rifkin DB, Hajjar KA. Annexin II-mediated plasmin generation activates TGF-beta3 during epithelial-mesenchymal transformation in the developing avian heart. Developmental Biology. 265: 140-54. PMID 14697359 DOI: 10.1016/J.Ydbio.2003.08.026 |
0.342 |
|
| 2004 |
Brownstein C, Deora AB, Jacovina AT, Weintraub R, Gertler M, Khan KM, Falcone DJ, Hajjar KA. Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages. Blood. 103: 317-24. PMID 14504107 DOI: 10.1182/Blood-2003-04-1304 |
0.782 |
|
| 2003 |
Markle RA, Han J, Summers BD, Yokoyama T, Hajjar KA, Hajjar DP, Gotto AM, Nicholson AC. Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells. Journal of Cellular Biochemistry. 90: 23-32. PMID 12938153 DOI: 10.1002/Jcb.10602 |
0.4 |
|
| 2002 |
Arzimanoglou II, Hansen LL, Chong D, Li Z, Psaroudi MC, Dimitrakakis C, Jacovina AT, Shevchuk M, Reid L, Hajjar KA, Vassilaros S, Michalas S, Gilbert F, Chervenak FA, Barber HR. Frequent LOH at hMLH1, a highly variable SNP in hMSH3, and negligible coding instability in ovarian cancer. Anticancer Research. 22: 969-75. PMID 12014680 |
0.694 |
|
| 2002 |
Kim J, Hajjar KA. Annexin II: a plasminogen-plasminogen activator co-receptor. Frontiers in Bioscience : a Journal and Virtual Library. 7: d341-8. PMID 11815288 DOI: 10.2741/Kim |
0.498 |
|
| 2001 |
Ishii H, Yoshida M, Hajjar KA, Tanaka A, Yasukochi Y, Shimokado K, Numano F. Potential role of recombinant annexin II in diabetic vascular injury Annals of the New York Academy of Sciences. 947: 308-311. PMID 11795280 DOI: 10.1111/J.1749-6632.2001.Tb03953.X |
0.404 |
|
| 2001 |
Brownstein C, Falcone DJ, Jacovina A, Hajjar KA. A mediator of cell surface-specific plasmin generation Annals of the New York Academy of Sciences. 947: 143-156. PMID 11795262 DOI: 10.1111/J.1749-6632.2001.Tb03937.X |
0.79 |
|
| 2001 |
Ishii H, Yoshida M, Hiraoka M, Hajjar KA, Tanaka A, Yasukochi Y, Numano F. Recombinant annexin II modulates impaired fibrinolytic activity in vitro and in rat carotid artery Circulation Research. 89: 1240-1245. PMID 11739291 DOI: 10.1161/Hh2401.101066 |
0.443 |
|
| 2001 |
Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, ... ... Hajjar KA, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Medicine. 7: 1194-201. PMID 11689883 DOI: 10.1038/Nm1101-1194 |
0.326 |
|
| 2001 |
Jacovina AT, Zhong F, Khazanova E, Lev E, Deora AB, Hajjar KA. Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation. The Journal of Biological Chemistry. 276: 49350-8. PMID 11679580 DOI: 10.1074/Jbc.M106289200 |
0.775 |
|
| 2001 |
Hajjar KA. Homocysteine: A sulph'rous fire Journal of Clinical Investigation. 107: 663-664. PMID 11254663 DOI: 10.1172/Jci12369 |
0.311 |
|
| 2001 |
Falcone DJ, Borth W, Khan KMF, Hajjar KA. Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II Blood. 97: 777-784. PMID 11157497 DOI: 10.1182/Blood.V97.3.777 |
0.419 |
|
| 2000 |
Hajjar KA, Deora A. New concepts in fibrinolysis and angiogenesis Current Atherosclerosis Reports. 2: 417-421. PMID 11122773 DOI: 10.1007/S11883-000-0080-6 |
0.4 |
|
| 2000 |
Ishii H, Yoshida M, Hajjar KA, Yasukochi Y, Numano F. Construction of recombinant adenoviral vector of annexin II Annals of the New York Academy of Sciences. 902: 311-314. PMID 10865854 DOI: 10.1111/J.1749-6632.2000.Tb06329.X |
0.427 |
|
| 2000 |
Hajjar KA, Acharya SS. Annexin II and regulation of cell surface fibrinolysis Annals of the New York Academy of Sciences. 902: 265-271. PMID 10865846 DOI: 10.1111/J.1749-6632.2000.Tb06321.X |
0.482 |
|
| 2000 |
Ma K, Simantov R, Zhang JC, Silverstein R, Hajjar KA, McCrae KR. High affinity binding of β2-glycoprotein I to human endothelial cells is mediated by annexin II Journal of Biological Chemistry. 275: 15541-15548. PMID 10809787 DOI: 10.1074/Jbc.275.20.15541 |
0.432 |
|
| 2000 |
Ling Q, Hajjar KA. Inhibition of endothelial cell thromboresistance by homocysteine Journal of Nutrition. 130. PMID 10721910 DOI: 10.1093/Jn/130.2.373S |
0.46 |
|
| 2000 |
Ishii H, Yoshida M, Yasukochi Y, Hajjar K, Tanaka A, Numano F. Recombinant annexin II upregulates plasmin generation on endothelial cells Atherosclerosis. 151: 20. DOI: 10.1016/S0021-9150(00)80087-8 |
0.437 |
|
| 1999 |
Hajjar KA, Krishnan S. Annexin II: A mediator of the plasmin/plasminogen activator system Trends in Cardiovascular Medicine. 9: 128-138. PMID 10639727 DOI: 10.1016/S1050-1738(99)00020-1 |
0.426 |
|
| 1999 |
Menell JS, Cesarman GM, Jacovina AT, McLaughlin MA, Lev EA, Hajjar KA. Annexin II and bleeding in acute promyelocytic leukemia. The New England Journal of Medicine. 340: 994-1004. PMID 10099141 DOI: 10.1056/Nejm199904013401303 |
0.729 |
|
| 1998 |
Hajjar KA, Jacovina AT. Modulation of annexin II by homocysteine: implications for atherothrombosis. Journal of Investigative Medicine : the Official Publication of the American Federation For Clinical Research. 46: 364-9. PMID 9805420 |
0.782 |
|
| 1998 |
Chacko G, Ling Q, Hajjar KA. Induction of acute translational response genes by homocysteine: Elongation factors-1α, -β, and -δ Journal of Biological Chemistry. 273: 19840-19846. PMID 9677419 DOI: 10.1074/Jbc.273.31.19840 |
0.354 |
|
| 1998 |
Camera M, Hajjar KA, Pan S, Szabo P, Vicart P, Paulin D, Weksler BB. Profibrinolytic properties characterize a stably transformed human endothelial cell line Blood Coagulation and Fibrinolysis. 9: 153-165. PMID 9622213 DOI: 10.1097/00001721-199803000-00006 |
0.466 |
|
| 1998 |
Hajjar KA, Mauri L, Jacovina AT, Zhong F, Mirza UA, Padovan JC, Chait BT. Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine. The Journal of Biological Chemistry. 273: 9987-93. PMID 9545344 DOI: 10.1074/Jbc.273.16.9987 |
0.774 |
|
| 1997 |
Hajjar KA, Menell JS. Annexin II: A novel mediator of cell surface plasmin generation Annals of the New York Academy of Sciences. 811: 337-349. PMID 9186609 DOI: 10.1111/J.1749-6632.1997.Tb52013.X |
0.414 |
|
| 1997 |
Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Alyonycheva TN, Safier LB, Hajjar KA, Posnett DN, Schoenborn MA, Schooley KA, Gayle RB, Maliszewski CR. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. The Journal of Clinical Investigation. 99: 1351-60. PMID 9077545 DOI: 10.1172/Jci119294 |
0.312 |
|
| 1997 |
Mitra D, Jaffe EA, Weksler B, Hajjar KA, Soderland C, Laurence J. Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells Blood. 89: 1224-1234. PMID 9028945 DOI: 10.1182/Blood.V89.4.1224 |
0.346 |
|
| 1997 |
Hajjar K, Mauri L, Zhong F, Mirza U, Chait B. 135 Tissue plasminogen activator binding to the tail domain of its endothelial cell receptor, annexin II: Direct modulation by homocysteine Fibrinolysis and Proteolysis. 11: 38. DOI: 10.1016/S0268-9499(97)80251-2 |
0.327 |
|
| 1996 |
Hajjar KA, Guevara CA, Lev E, Dowling K, Chacko J. Interaction of the fibrinolytic receptor, annexin II, with the endothelial cell surface. Essential role of endonexin repeat 2 Journal of Biological Chemistry. 271: 21652-21659. PMID 8702954 DOI: 10.1074/Jbc.271.35.21652 |
0.476 |
|
| 1995 |
Hajjar KA. Changing concepts in fibrinolysis Current Opinion in Hematology. 2: 345-350. PMID 9372018 DOI: 10.1097/00062752-199502050-00004 |
0.311 |
|
| 1995 |
Hajjar KA. Cellular receptors in the regulation of plasmin generation Thrombosis and Haemostasis. 74: 294-301. PMID 8578475 DOI: 10.1055/S-0038-1642693 |
0.362 |
|
| 1995 |
Marcus AJ, Safier LB, Broekman MJ, Islam N, Fliessbach JH, Hajjar KA, Kaminski WE, Jendraschak E, Silverstein RL, Von Schacky C. Thrombosis and inflammation as multicellular processes: Significance of cell-cell interactions Thrombosis and Haemostasis. 74: 213-217. PMID 8578460 DOI: 10.1055/S-0038-1642679 |
0.384 |
|
| 1995 |
Camera M, Paulin D, Vicart P, Hajjar KA, Weksler BB. Analysis of the fibrinolytic capacity of an immortalized human endothelial cell line Pharmacological Research. 31: 240. DOI: 10.1016/1043-6618(95)87219-1 |
0.319 |
|
| 1994 |
Hajjar KA, Reynolds CM. α-Fucose-mediated binding and degradation of tissue-type plasminogen activator by HepG2 cells Journal of Clinical Investigation. 93: 703-710. PMID 8113404 DOI: 10.1172/Jci117023 |
0.385 |
|
| 1994 |
Cesarman GM, Guevara CA, Hajjar KA. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation Journal of Biological Chemistry. 269: 21198-21203. PMID 8063741 |
0.34 |
|
| 1994 |
Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. The Journal of Biological Chemistry. 269: 21191-7. PMID 8063740 |
0.782 |
|
| 1993 |
Shih GC, Hajjar KA. Plasminogen and Plasminogen Activator Assembly on the Human Endothelial Cell Proceedings of the Society For Experimental Biology and Medicine. 202: 258-264. PMID 8437979 DOI: 10.3181/00379727-202-43534A |
0.431 |
|
| 1993 |
Hajjar KA. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor Journal of Clinical Investigation. 91: 2873-2879. PMID 8390492 DOI: 10.1172/Jci116532 |
0.454 |
|
| 1992 |
Hajjar KA. Assembly of plasmin-generating proteins on the surface of human endothelial cells Annals of Epidemiology. 2: 419-426. PMID 1342292 DOI: 10.1016/1047-2797(92)90091-4 |
0.424 |
|
| 1991 |
Marcus AJ, Safier LB, Hajjar KA, Ullman HL, Islam N, Broekman MJ, Eiroa AM. Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells. The Journal of Clinical Investigation. 88: 1690-6. PMID 1939654 DOI: 10.1172/Jci115485 |
0.395 |
|
| 1991 |
Nachman RL, Hajjar KA. Endothelial cell fibrinolytic assembly Annals of the New York Academy of Sciences. 614: 240-249. PMID 1902639 DOI: 10.1016/0741-5214(90)90119-U |
0.43 |
|
| 1990 |
Hajjar KA, Hamel NM. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase Journal of Biological Chemistry. 265: 2908-2916. PMID 2154465 |
0.313 |
|
| 1989 |
Hajjar KA, Gavishi D, Breslow JL, Nachman RL. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis Nature. 339: 303-305. PMID 2524666 DOI: 10.1038/339303A0 |
0.451 |
|
| 1988 |
Hajjar KA, Nachman RL. Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface Journal of Clinical Investigation. 82: 1769-1778. PMID 3141482 DOI: 10.1172/Jci113790 |
0.446 |
|
| 1988 |
Staiano-Coico L, Hajjar DP, Hefton JM, Hajjar KA, Kimmel M. Interactions of arterial cells: III. Stathmokinetic analyses of smooth muscle cells cocultured with endothelial cells Journal of Cellular Physiology. 134: 485-490. PMID 2450881 DOI: 10.1002/Jcp.1041340322 |
0.37 |
|
| 1987 |
Hajjar KA, Hajjar DP, Silverstein RL, Nachman RL. Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells Journal of Experimental Medicine. 166: 235-245. PMID 3598461 DOI: 10.1084/Jem.166.1.235 |
0.363 |
|
| 1987 |
Hajjar KA, Hamel NM, Harpel PC, Nachman RL. Binding of tissue plasminogen activator to cultured human endothelial cells Journal of Clinical Investigation. 80: 1712-1719. PMID 3119664 DOI: 10.1172/Jci113262 |
0.399 |
|
| 1986 |
Nachman RL, Hajjar KA, Silverstein RL, Dinarello CA. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor Journal of Experimental Medicine. 163: 1595-1600. PMID 3086483 DOI: 10.1084/Jem.163.6.1595 |
0.385 |
|
| Show low-probability matches. |